These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 19167603

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 5. Resource utilization impact of topiramate for migraine prevention in the managed-care setting.
    Wertz DA, Quimbo RM, Yaldo AZ, Rupnow MF.
    Curr Med Res Opin; 2009 Feb; 25(2):499-503. PubMed ID: 19192995
    [Abstract] [Full Text] [Related]

  • 6. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine.
    Keskinbora K, Aydinli I.
    Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801
    [Abstract] [Full Text] [Related]

  • 7. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV, Jevoux CC.
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [Abstract] [Full Text] [Related]

  • 8. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF, Parada VA, Drinkard R, Zweifler RM, Key KF.
    Headache; 2005 Apr; 45(7):932-5. PubMed ID: 15985112
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A, Song D, Zhang L, Li C.
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [Abstract] [Full Text] [Related]

  • 12. The effect of migraine prophylaxis on migraine-related resource use and productivity.
    Láinez MJ.
    CNS Drugs; 2009 Sep; 23(9):727-38. PubMed ID: 19689164
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Triptan persistency among newly initiated users in a pharmacy claims database.
    Katić BJ, Rajagopalan S, Ho TW, Chen YT, Hu XH.
    Cephalalgia; 2011 Mar; 31(4):488-500. PubMed ID: 20937605
    [Abstract] [Full Text] [Related]

  • 15. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Mar; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 20. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM, Schultz LL, Gilkey SJ.
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.